Qisda

Participants

Chairman

President

CFO

GM, Information Technology Business Group

GM, Commercial & Industrial Business Group

GM, Medical Business Group

GM, Business Solutions Business Group GM, Networking & Communication Business Group CIO

Peter Chen Joe Huang Jasmin Hung Daniel Hsueh Yuchin Lin Harry Yang Michael Lee April Huang Michael Wang

Agenda

1. Company Profile

CFO

Jasmin Hung

2. 2023 Q4 Financial Results

3. Business Update and Outlook

Chairman Peter Chen President Joe Huang GM of each Business Group

4. Q&A

Safe Harbor Notice

We have made forward-looking statements in the presentation. Our forwardstatements contain information other our looking regarding, among things, financial conditions, future expansion plans and business strategies. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that these expectations and projections are reasonable, such forward-looking statements are inherently subject to risks, uncertainties, and assumptions about us.

We undertake no to or revise obligation publicly update any forward-looking statements whether as a result of new information, future events or otherwise. In light of these risks, uncertainties and assumptions, the forward-looking events might not occur and our actual results could differ materially from those anticipated in these forward-looking statements.

Qisda Group

Qisda is a global technology group with businesses spanning information technology, medical, smart business solutions, and networking communication.

Year Established 1984 IPO Year 1996 (Ticker 2352) Capital (NTD) 19.7B

Awards

2023 Winning 12 Awards of TCSA 2023 Winning 3 Awards of AREA 2023 HR Asia:

“ Best Companies to Work For” (2019 – 2023 consecutively) 2023 Winning 9 Awards of TSAA

Global Presence

Manufacturing Sites ： Taiwan, China, Vietnam Sales Offices ： 200+ Locations Worldwide R&D Centers ： Taiwan, China No. of Employees ： 27,000+

2023 Revenue NTD $203.6B (USD$ 6.6B) 2022 Revenue NTD $239.8B (USD$ 8.2B) Revenue Breakdown (2023) Asia 50% Americas 29% Europe 19% Others 2%

AREA: Asia Responsible Enterprise Awards TSAA: Taiwan Sustainability Action Awards *TCSA: Taiwan Corporate Sustainability Awards

Business Groups

Qisda Grou p

(2023 whole year)

										(2023 whole year)


	IT		MEDICAL		BSG			NCG		OTHERS
Information Technology					Business Solutions		Networking & Communication
	(45% + 8%)		(12%)			(16%)		(14%)		(5%)
	106.5B		24.6B		32.7B			28.3B		11.5B
➢ ➢ ➢ ➢	Displays • Gaming • High-end • General Projectors IT_Other 71.1 B (35%) 11.0 B (5%) 8.8 B (5%) 15.6 B (8%) IT_HVA • Prof. Display Module • Integration Solutions	➢ ➢ ➢	Medical Services • BenQ Medical Center in Nanjing and Suzhou • Medical Management Consulting Equipment & Consumables • Operating Table & Surgical Light • Ultrasound • Intraoral Scanner • Hearing Aids • Dentistry Consumables Dialyzer • Dialysis Equipment & Consumables • Ethanol Solution	➢ ➢ ➢	IT Intelligence Partner • AI Computing • Cybersecurity • Edge to Cloud Integration • Digital Transformation OT Intelligence Partner • Green Energy • Automation • Industrial Computer OMO Solution		➢ ➢ ➢ ➢	LAN/MAN • Data Switch Wireless Broadband • Small Cell • Wireless Router Digital Multimedia • IP Camera • mmWave Radar System Integration • Network System Service • Digital Media System Service	➢ Equity Method • Darfon • Norbel Baby • Rapidtek • Topview ➢ FVOCI KEY INVESTMENTS ➢ Material • Functional Film • Advanced Battery Materials ➢ Other products
										• AUO

Revenue (NTD)

Purple columns represent “high value-added businesses”, which account for 50% of total revenue. Medical, BSG, NCG 2023 revenue scale is between NTD 20B to 35B, reaching a meaningful economies of scale.

2023 Q4 Highlights

Q4 Gross margin was 16.2%, exceeding 16% for three consecutive quarters, highest in the same period in 20 years.
Revenue was 50.7B (YoY -10%, QoQ +1%), net income attributable to Qisda reached 0.43B (YoY +50M, +15%), EPS was 0.22 (+0.03).
HVA businesses Q4 revenue was 24.5B (QoQ +300M, +1%).
Medical: Revenue grew 6% QoQ. GM%, OI% and OI amount grew QoQ and YoY.
NCG: Revenue grew 16% QoQ. OI% and OI amount grew QoQ.
BSG: Revenue decreased 7% QoQ. GM% increased QoQ and YoY.

◆ IT business Q4 revenue was 27B (QoQ +400M, +1%).

IT_Original: Revenue increased by 700M QoQ,+3%, Display’s revenue has risen for three consecutive quarters and grew YoY as well.
IT_HVA: Revenue decreased by 320M QoQ, -9%, GM% decreased QoQ.

2023 Whole Year Highlights

Whole year revenue reached 203.6B (YoY -36.2B, -15%); Gross margin was 16.2% (YoY +1.8ppt), highest in 20 years.
IT business revenue was 106.5B (-35B, -25%), mainly due to decrease in demand for IT products.
HVA businesses revenue was 101.2B, exceeding 100B for 2 consecutive years, account for 50% of whole year revenue (YoY +5%)
- Medical: Revenue grew 20% YoY. GM%, OI% and OI amount grew YoY.
- BSG: Revenue grew 3% YoY. GM% grew YoY.
- NCG: Revenue decreased 16% YoY. GM% and OI % decreased due to inventory adjustments on clients side.
Net income attributable to Qisda decreased around 5.3B YoY; this is mainly due to the sale of 100% shares in BenQ (Hong Kong) Limited in 2022, which contributed a gain of approximately NTD 5.3B.
Cash dividend NTD 1 .2 per share, payout ratio around 79%.
Group entities apply for public listing sequentially:
Norbel Baby (6844) will be listed on Taipei Exchange (TPEx) on Mar. 8, 2024.
Data Image (3168) will be listed on the Taiwan Stock Exchange (TWSE) on March 26, 2024.
BenQ BM Holding Cayman Corp.: The board resolved on Jan. 18, 2024 to prepare and submit its listing application to HKEX for initial public offering (IPO).

Consolidated Statement of Comprehensive Income (Quarterly)

Unit : NT$ Million

Net Sales

Cost of Goods Sold

Gross Margin Operating Expenses Operating Income Net non-operating Income Profit(Loss) before Tax Net Income

Net income attributable to Qisda EPS (NT$) (a)

	50,667 100% (42,461) 8,207 16.2% (7,339) -14.5% 868 1.7% (5) 862 1.7% 675 1.3% 426 0.8% $0.22 2023 Q4		56,117 100% (47,351) 8,766 15.6% (7,289) -13.0% 1,477 2.6% (335) 1,141 2.0% 1,016 1.8% 372 0.7% $0.19 2022 Q4	amt g% (5,450) -10% 4,891 (559) -6% (50) (609) -41% 330 (279) -24% (341) -34% 54 15% $0.03 YoY	50,370 100% (41,993) 8,377 16.6% (7,027) -14.0% 1,350 2.7% 774 2,125 4.2% 1,549 3.1% 1,202 2.4% $0.61 2023 Q3	amt g% 297 1% (468) (171) -2% (312) (483) -36% (780) (1,262) -59% (875) -56% (776) -65% -$0.39 QoQ

(a) EPS was calculated based on total weighted-averaged outstanding shares (1,967m shares)

Consolidated Statement of Comprehensive Income (YTD)

Unit : NT$ Million

Unit : NT$ Million
Net Sales Cost of Goods Sold Gross Margin Operating Expenses Operating Income Net non-operating Income Profit(Loss) before Tax Net Income Net income attributable to Qisda EPS (NT$) (a)	203,595 100% (170,519) 33,076 16.2% (28,065) -13.8% 5,011 2.5% 1,309 6,320 3.1% 4,516 2.2% 2,976 1.5% $1.51 2023	2022
		239,837 100% (205,276)
		34,561 14.4% (28,709) -12.0%
		5,852 2.4% 10,771
		16,623 6.9%
		11,079 4.6%
		8,252 3.4% $4.20

YTD YoY amt % g (36,243) -15% 34,757 (1,485) -4% 644 (841) -14% (9,462) 10 304 -62% ( , ) 6 563 -59% ( , ) (5,276) -64% -$2.68

(a) EPS was calculated based on total weighted-averaged outstanding shares (1,967m shares)

Consolidated Balance Sheet Highlights

Unit : NT$ Million

Cash & Equivalent Accounts Receivable Inventory L-T Investments Financial assets at fair value through other comprehensive income–non-current Total Assets Fin. Debt Accounts Payable Toal Liabilities Equity		25,473 14% 38,042 20% 37,931 20% 8,314 4% 188,424 100% 64,521 34% 30,468 16% 124,330 66% 64,094 34% 12,070 6% 2023.12.31		23,316 12% 40,730 22% 38,386 20% 8,534 5% 189,027 100% 62,351 33% 33,068 17% 124,889 66% 64,138 34% 11,328 6% 2023.09.30	amt g% 2,157 9% (2,688) -7% (454) -1% (220) -3% (603) 0% 2,171 3% (2,600) -8% (559) 0% (45) 0% 742 7% QoQ	amt g% 31,203 16% (5,730) -18% 40,150 21% (2,108) -5% 43,870 23% (5,939) -14% 5,479 3% 2,834 52% 193,416 100% (4,992) -3% 62,687 32% 1,834 3% 29,038 15% 1,430 5% 125,478 65% (1,148) -1% 67,937 35% (3,844) -6% 10,231 5% 1,839 18% 2022.12.31 YoY

Financial Ratios

AR Turnover (Days) Inventory Turnover (Days) AP Turnover (Days) Cash Conversion Cycle (Days) Current ratio		73 88 64 97 127% 2023.12.31		76 88 66 98 125% 2023.09.30	-3 70 +3 +0 84 +4 -2 62 +2 -1 92 +5 +2 ppt 143% -16 ppt QoQ 2022.12.31 YoY

Financial Trend – Quarterly Trend

⚫ Q4 Gross Margin was 16.2%, exceeding 16% for three consecutive quarters.

==> picture [353 x 153] intentionally omitted <==

----- Start of picture text -----

NT$ 100M Revenue
1,000
g% -4% -7% -10% 3% -3% 1%
500
601 561 504 521 504 507
0
Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23
----- End of picture text -----

==> picture [336 x 157] intentionally omitted <==

----- Start of picture text -----

NT$ 100M
Operating Income (OI)
40
g% -65% 87% -9% 7% -6% -36%
20
14.8 13.5 14.4 13.5
7.9 8.7
0
Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23
----- End of picture text -----

==> picture [43 x 7] intentionally omitted <==

----- Start of picture text -----

NT$ 100M
----- End of picture text -----

==> picture [364 x 178] intentionally omitted <==

----- Start of picture text -----

GM% & OI%
%
20
15.6 15.8 16.3 16.6 16.2
14.4
15
10
5
1.31 2.63 2.68 2.77 2.68 1.71
0
Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23
GM% OI%
----- End of picture text -----

==> picture [362 x 179] intentionally omitted <==

----- Start of picture text -----

YTD GM% & OI%
%
20
16.2
15 13.6 14.0 14.4 14.4
12.4
10
5 2.94 3.67 3.45 3.26 2.44 2.46
0
2018 2019 2020 2021 2022 2023
Yearly Yearly Yearly Yearly Yearly Yearly
----- End of picture text -----

Financial Trend – Q4 YOY

⚫ Gross Margins for Q4 and the year were both 16.2%, the highest level in 20 years.

==> picture [356 x 152] intentionally omitted <==

----- Start of picture text -----

NT$ 100M Revenue
1,000
g% 14% 8% 25% 8% -9% -10%
500
571 619 561
424 459 507
0
Q4'18 Q4'19 Q4'20 Q4'21 Q4'22 Q4'23
----- End of picture text -----

Operating Income (OI)

NT$ 100M

==> picture [343 x 132] intentionally omitted <==

----- Start of picture text -----

40
g% 40% 7% 55% -16% -16% -41%
20
20.9
17.5
12.6 13.5 14.8
8.7
0
Q4'18 Q4'19 Q4'20 Q4'21 Q4'22 Q4'23
----- End of picture text -----

==> picture [369 x 175] intentionally omitted <==

----- Start of picture text -----

GM% & OI%
%
20
16.2
15.6
14.3
15 12.8 13.7
12.0
10
5 2.98 2.93 3.66 2.84 2.63
1.71
0
Q4'18 Q4'19 Q4'20 Q4'21 Q4'22 Q4'23
GM% OI%
----- End of picture text -----

==> picture [366 x 175] intentionally omitted <==

----- Start of picture text -----

YTD GM% & OI%
%
20
16.2
15 13.6 14.0 14.4 14.4
12.4
10
5 2.94 3.67 3.45 3.26 2.44 2.46
0
2018 2019 2020 2021 2022 20232023
Yearly Yearly Yearly Yearly Yearly Yearly
----- End of picture text -----

Business Group Revenue Trend – Quarterly Trend

==> picture [942 x 390] intentionally omitted <==

----- Start of picture text -----

High-value added (HVA) Medical BSG
NT$ 100M g% 7% 0% -7% 2% -9% 1% NT $ 100M g% 7% 1% 4% 7% 2% 6% NT$ 100M g% 6% 2% -3% 1% 4% -7%
300 100 100
250 80 80
200
60 60
150
281 280
260 264 242 245 40 40 82 83 81 82 85 79
100 55 55 57 61 62 66
20 20
50
0 0 0
Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23
NCG IT_HVA IT_Original
NT$ 100M
NT$ 100M g% 11% 0% -15% -2% -24% 16% g% 1% -7% -13% 2% -17% -9% NT$ 100M g% -13% -12% -15% 3% 3% 3%
100 100 300
250
80 80
200
60 60
150 290
92 92 255
40 79 77 68 40 100 217 224 230 237
59 53 49
20 20 43 44 36 33 50
0 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 0 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 0 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23
----- End of picture text -----

High-Value added (HVA)= Medical + BSG+ NCG + IT_HVA
IT_Original = Displays + Projectors + IT_Other
IT_HVA: TopView was changed to equity method from consolidated subsidiary

Financial highlights by Business Group – Q4

NT$ 100M
Business Group	2023 Q4		YoY		QoQ
	Revenue Portion Revenue	GM% Range	Revenue Amount Revenue Growth Rate	GM% Range	Revenue Amount Revenue Growth Rate	GM% Range

Medical	13% 66	20-25	+10 +19% unchanged		+4 +6% unchanged
BSG	16% 79	20-25	-4 -5 % upward		-6 -7% upward
NCG	13% 68	15-20	-24 -26 % unchanged		+9 16% downward
IT_HVA	7% 33	20-25	-16 -33 % downward		-3 -9% downward
IT_Original	47% 237	10-15	-18 -7 % upward		+7 +3% unchanged
Others	5% 24	15-20	-2 -7 % unchanged		-8 -24 % unchanged

• IT_HVA: TopView was changed to equity method from consolidated subsidiary

Revenue Breakdown by Business (Quarterly)

==> picture [930 x 398] intentionally omitted <==

----- Start of picture text -----

100%
Materials
5% 5% 5% 5% 6% 6% 5%
and Others
13% 15% 16% 16% 15% 12% 13% NCG
80%
BSG
12%
14% 17% 16%
15% 16% 16%
48% Medical
8%
9%
60% 10% 12% 13% IT_HVA
8% 11% 12%
9%
6% 9% 7% 7% IT_Other
9% 8%
5% 8% 4% 4%
6%
40% 5% 4% 5% 5% Projector
6%
7% 6% 5%
Display
20% 42%
36% 37%
34% 33% 32% 33%
0%
Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23
----- End of picture text -----

*BSG: Business Solutions Group

*IT: IT products
*IT_Other: other IT products

*NCG: Networking and Communication Group

*IT_Display: Displays
*IT_Projector: Projectors
*Medical: medical services, equipment & consumables, dialyzer, medical management consulting
*IT_HVA: prof. display module, integrated solutions, high-end video surveillance
(TopView was changed to equity method from consolidated subsidiary)
*Materials and Others: BenQ Materials and other products

High Value-added Revenue Portion Trend

• High value-added businesses YTD revenue accounts for 50%.

==> picture [908 x 334] intentionally omitted <==

----- Start of picture text -----

% Quarterly Yearly
60% 60%
52% 51%
50% 50%
48% 48%
50% 47% 50% 45%
9% 9% 8% 7% 7% 41% 8%
9%
40% 40% 9%
35%
9%
16% 15% 12% 13% 14%
16%
6%
30% 15% 30%
14%
23%
12%
9%
18%
20% 16% 16% 17% 16% 20% 7% 16%
15%
14% 5% 13%
13% 13%
9%
10% 10% 7%
9% 10% 11% 12% 12% 13% 6% 7% 6% 7% 9% 12%
0% 0%
Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 2018 2019 2020 2021 2022 202323
Yearly Yearly Yearly Yearly Yearly Yearly
Medical BSG NCG IT_HVA HVA + IT_HVA
----- End of picture text -----

IT_HVA: : TopView was changed to equity method from consolidated subsidiary

Qisda Group’s Listed Companies Results (YoY)

			2023	2023	2023	2022	2022	2022	YoY Differences	YoY Differences	YoY Differences
Business Group	Company	Qisda's stake	Revenue (NTD Million)	Net Income (NTD Million)*	EPS (NTD)	Revenue (NTD Million)	Net Income (NTD Million)*	EPS (NTD)	Revenue (NTD Million) YoY%	Net Income (NTD Million) YoY%*	EPS (NTD)
IT	DataImage (ROTC)	38.4%	3,916	279	4.02	4,922	422	6.08	-1,005 -20%	-143 -34%	-2.06
	SIMULA(OTC)	51.1%	2,039	-83	-1.04	4,231	249	3.12	-2,192 -52%	-333 -133%	-4.16
Medical	BenQ Medical Tech(	55.0%	4,543	115	2.57	4,377	180	4.04	166 4%	-66 -36%	-1.47
	ConcordMed(ROTC)	22.0%	833	43	1.28	889	51	1.52	-56 -6%	-8 -16%	-0.24
	DIVA(OTC)	13.6%	894	73	1.25	949	50	0.85	-55 -6%	23 46%	+0.41 highest in the same period in 8years
BSG	DFI(TSE)	55.1%	9,184	362	3.16	10,992	528	4.61	-1,808 -16%	-167 -32%	-1.45
	AEWIN(OTC)	28.3%	1,969	27	0.45	2,463	154	2.60	-494 -20%	-127 -83%	-2.15
	Ace Pillar(TSE)	26.5%	3,052	-21	-0.19	3,762	79	0.70	-711 -19%	-100 -127%	-0.89
	Partner Tech(ROTC)	68.2%	2,717	109	1.45	2,736	136	1.81	-19 -1%	-27 -20%	-0.36
	MetaAge (TSE)	51.4%	19,814	592	3.14	17,311	413	2.19	2,503 14%	179 43%	+0.95 highest in the same period in 22years
NCG	Alpha(TSE)	60.0%	28,272	548	1.01	33,634	917	1.69	-5,362 -16%	-369 -40%	-0.68
	Hitron(TSE)	37.3%	9,404	5	0.02	12,318	482	1.50	-2,915 -24%	-477 -99%	-1.49
	IDT(OTC)	18.7%	2,243	262	6.26	2,048	215	5.43	195 10%	47 22%	+0.83 highest in the same period in 2years
Materials	BenQ Materials (TSE)	43.6%	17,128	414	1.29	15,540	1,296	4.04	1,587 10%	-881 -68%	-2.75

Net income attributable to Qisda

IT : TopView was changed to equity method from consolidated subsidiary

2024 Q1 Outlook

➢ Respond Prudently to Global Economic Uncertainties

Recent factors such as regional wars, the China real estate crisis, combined with inflation and rising interest rates, have all impacted the pace of global market recovery. This situation brings challenges to operations, which require cautious response.
While the balance of market supply and demand has gradually been restored, the recovery of market demand appears to be relatively weak in Q1 2024.

➢ Business Drivers

◆ High Value-added business:

The operation of hospital business and medical products is on the rise.
BSG is optimistic about the demand of digital transformation and IT infrastructure.
NCG is preparing for long-term growth opportunities.
IT business : Demand is slowly picking up and the optimization of IT high value-added product lines is in progress.
Group entities apply for public listing sequentially.

Qisda ESG Commitment and Recognition

==> picture [86 x 66] intentionally omitted <==

Qisda Group commits in expand influence in sustainability,

➢ 7 companies totally won over 30 Sustainability Awards in 2023.

==> picture [107 x 31] intentionally omitted <==

==> picture [85 x 85] intentionally omitted <==

Companies with approved SBTi targets
• S&P Global CSA Score 2023 Top 5%

Sustainability Report

BenQ Materials GCSA ESG Report

Platinum Award

Silver Award

TCSA Overall performance Top 100 Sustainability Model Award
Asia Pacific Enterprise Awards Entrepreneur of The Year Award

Overall performance Alpha Networks ESG Report

Top 100 Sustainability Model Award Gold Award

Dow Jones Sustainability Emerging Markets #3 in the THQ (Computers & Peripherals and Office Electronics) Taiwan
• Sustainability Report Platinum Award
• Global Corporate Sustainability Award (GCSA) ESG Sustainability Report – Bronze Award
Best Companies to Work for in Asia Have been consecutive winners for five years
Asia Responsible Enterprise Awards Green Leadership Award / Corporate Sustainability Award

Hitron ESG Report DFI ESG Report

ESG Report

MetaAge

One-way performance

ACE

PILLAR ESG Report

Silver Award

Gold Award

Silver Award

Talent Development Leader

Bronze Award

EEWH Green Building Label Silver Class

2024 Strategic Directions

IT

Continuous development high-end displays such as OLED display and medical displays
Utilize VN leading advantages, continue to increase yield and add new product lines to expand benefits
Development in interactive flat panel display
Expansion in medical oral scanner

BSG

Edge to Cloud Integration
Cybersecurity
HPC (AI computing)
Green energy, automation (smart manufacturing),

Medical

Medical devices and pharmaceuticals as dual growth engines to expand in distribution channels
In-depth development in dialysis market
Expansion in healthcare service
Development in smart healthcare

NCG

Increase penetration in telecom markets
Investment in low earth orbit satellite technologies
Enlarge 5G market share

new infrastructure

Medical Overview

==> picture [939 x 477] intentionally omitted <==

----- Start of picture text -----

Surgical Equipment Ultrasound Medical Display Dental
BenQ Medical Center, Guigang Donhui Hospital Medical Supplies
Nanjing & Suzhou Consultancy
Medical
Medical Medical Medical Isopropyl
Pharmaceutical channel Hearing Service Service Equipment & Comsuables Facemask Alcohol
Consumables
Smart Hemo
Healthcare dialysis
AI Health
Examination Dialyzer Dialysate/Dialysis Powder
Dialysis
Machine
Smart Hospital
Smart Operation Room
Smart Dialysis Center
Digital dentistry Genetic Test Cell Therapy
Dialysis Center
----- End of picture text -----

Pharmaceutical channel Hearing Service

AI assistant

Qisda — Annual Report 2023

52023_rns_2024-03-06_22929412-c1c3-4099-bc19-242b6ac0d6db.pdf

Participants

Agenda

1. Company Profile

Jasmin Hung

2. 2023 Q4 Financial Results

Safe Harbor Notice

Qisda Group

Business Groups

Qisda Grou p

(2023 whole year)

Revenue (NTD)

2023 Q4 Highlights

◆ IT business Q4 revenue was 27B (QoQ +400M, +1%).

2023 Whole Year Highlights

Consolidated Statement of Comprehensive Income (Quarterly)

Unit : NT$ Million

Net Sales

Consolidated Statement of Comprehensive Income (YTD)

Unit : NT$ Million

(a) EPS was calculated based on total weighted-averaged outstanding shares (1,967m shares)

Consolidated Balance Sheet Highlights

Unit : NT$ Million

Financial Ratios

Financial Trend – Quarterly Trend

Financial Trend – Q4 YOY

Operating Income (OI)

NT$ 100M

Business Group Revenue Trend – Quarterly Trend

Financial highlights by Business Group – Q4

Revenue Breakdown by Business (Quarterly)

High Value-added Revenue Portion Trend

• High value-added businesses YTD revenue accounts for 50%.

Qisda Group’s Listed Companies Results (YoY)

2024 Q1 Outlook

➢ Respond Prudently to Global Economic Uncertainties

➢ Business Drivers

◆ High Value-added business:

Qisda ESG Commitment and Recognition

Qisda Group commits in expand influence in sustainability,

Qisda

Sustainability Report

Platinum Award

MetaAge

2024 Strategic Directions

IT

BSG

Medical

NCG

Medical Overview

More from Qisda

Qisda Annual Report 2023